trending Market Intelligence /marketintelligence/en/news-insights/trending/Qsjm0MqTt_q6feMQCDLSzw2 content esgSubNav
In This List

Shanghai Fosun completes stake acquisition in Indian generic maker

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Shanghai Fosun completes stake acquisition in Indian generic maker

Shanghai Fosun Pharmaceutical (Group) Co. Ltd. completed its acquisition of a 74% stake in Indian generic maker Gland Pharma Ltd.

Following completion of the $1.1 billion deal, Gland Pharma is now an indirect non-wholly owned subsidiary of Shanghai Fosun.